▶ 調査レポート

世界のオレキシン受容体タイプ2市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Orexin Receptor Type 2 Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のオレキシン受容体タイプ2市場規模・現状・予測(2021年-2027年) / Global Orexin Receptor Type 2 Market Size, Status and Forecast 2021-2027 / QFJ1-5917資料のイメージです。• レポートコード:QFJ1-5917
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、オレキシン受容体タイプ2の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(HTL-6641、MK-8133、Lemborexant、OPN-021、YNT-185、その他)、用途別市場規模(不眠症、ナルコレプシー、睡眠障害、大うつ病性障害)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・オレキシン受容体タイプ2の市場動向
・企業の競争状況、市場シェア
・オレキシン受容体タイプ2の種類別市場規模と予測2016-2027(HTL-6641、MK-8133、Lemborexant、OPN-021、YNT-185、その他)
・オレキシン受容体タイプ2の用途別市場規模と予測2016-2027(不眠症、ナルコレプシー、睡眠障害、大うつ病性障害)
・オレキシン受容体タイプ2の北米市場規模2016-2027(アメリカ、カナダ)
・オレキシン受容体タイプ2の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・オレキシン受容体タイプ2のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・オレキシン受容体タイプ2の中南米市場規模2016-2027(メキシコ、ブラジル)
・オレキシン受容体タイプ2の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Actelion Pharmaceuticals Ltd、Eisai Co Ltd、Evotec AG、Heptares Therapeutics Ltd、Idorsia Ltd、Johnson & Johnson、Merck & Co Inc、OptiNose US Inc、Yangtze River Pharmaceutical Group)
・結論

Market Analysis and Insights: Global Orexin Receptor Type 2 Market
The global Orexin Receptor Type 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orexin Receptor Type 2 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orexin Receptor Type 2 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orexin Receptor Type 2 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orexin Receptor Type 2 market.

Global Orexin Receptor Type 2 Scope and Market Size
Orexin Receptor Type 2 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orexin Receptor Type 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others

Segment by Application
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HTL-6641
1.2.3 MK-8133
1.2.4 Lemborexant
1.2.5 OPN-021
1.2.6 YNT-185
1.2.7 Others
1.3 Market by Application
1.3.1 Global Orexin Receptor Type 2 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Insomnia
1.3.3 Narcolepsy
1.3.4 Sleep Disorders
1.3.5 Major Depressive Disorder
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Orexin Receptor Type 2 Market Perspective (2016-2027)
2.2 Orexin Receptor Type 2 Growth Trends by Regions
2.2.1 Orexin Receptor Type 2 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Orexin Receptor Type 2 Historic Market Share by Regions (2016-2021)
2.2.3 Orexin Receptor Type 2 Forecasted Market Size by Regions (2022-2027)
2.3 Orexin Receptor Type 2 Industry Dynamic
2.3.1 Orexin Receptor Type 2 Market Trends
2.3.2 Orexin Receptor Type 2 Market Drivers
2.3.3 Orexin Receptor Type 2 Market Challenges
2.3.4 Orexin Receptor Type 2 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Orexin Receptor Type 2 Players by Revenue
3.1.1 Global Top Orexin Receptor Type 2 Players by Revenue (2016-2021)
3.1.2 Global Orexin Receptor Type 2 Revenue Market Share by Players (2016-2021)
3.2 Global Orexin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Orexin Receptor Type 2 Revenue
3.4 Global Orexin Receptor Type 2 Market Concentration Ratio
3.4.1 Global Orexin Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orexin Receptor Type 2 Revenue in 2020
3.5 Orexin Receptor Type 2 Key Players Head office and Area Served
3.6 Key Players Orexin Receptor Type 2 Product Solution and Service
3.7 Date of Enter into Orexin Receptor Type 2 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Orexin Receptor Type 2 Breakdown Data by Type
4.1 Global Orexin Receptor Type 2 Historic Market Size by Type (2016-2021)
4.2 Global Orexin Receptor Type 2 Forecasted Market Size by Type (2022-2027)

5 Orexin Receptor Type 2 Breakdown Data by Application
5.1 Global Orexin Receptor Type 2 Historic Market Size by Application (2016-2021)
5.2 Global Orexin Receptor Type 2 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Orexin Receptor Type 2 Market Size (2016-2027)
6.2 North America Orexin Receptor Type 2 Market Size by Type
6.2.1 North America Orexin Receptor Type 2 Market Size by Type (2016-2021)
6.2.2 North America Orexin Receptor Type 2 Market Size by Type (2022-2027)
6.2.3 North America Orexin Receptor Type 2 Market Size by Type (2016-2027)
6.3 North America Orexin Receptor Type 2 Market Size by Application
6.3.1 North America Orexin Receptor Type 2 Market Size by Application (2016-2021)
6.3.2 North America Orexin Receptor Type 2 Market Size by Application (2022-2027)
6.3.3 North America Orexin Receptor Type 2 Market Size by Application (2016-2027)
6.4 North America Orexin Receptor Type 2 Market Size by Country
6.4.1 North America Orexin Receptor Type 2 Market Size by Country (2016-2021)
6.4.2 North America Orexin Receptor Type 2 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Orexin Receptor Type 2 Market Size (2016-2027)
7.2 Europe Orexin Receptor Type 2 Market Size by Type
7.2.1 Europe Orexin Receptor Type 2 Market Size by Type (2016-2021)
7.2.2 Europe Orexin Receptor Type 2 Market Size by Type (2022-2027)
7.2.3 Europe Orexin Receptor Type 2 Market Size by Type (2016-2027)
7.3 Europe Orexin Receptor Type 2 Market Size by Application
7.3.1 Europe Orexin Receptor Type 2 Market Size by Application (2016-2021)
7.3.2 Europe Orexin Receptor Type 2 Market Size by Application (2022-2027)
7.3.3 Europe Orexin Receptor Type 2 Market Size by Application (2016-2027)
7.4 Europe Orexin Receptor Type 2 Market Size by Country
7.4.1 Europe Orexin Receptor Type 2 Market Size by Country (2016-2021)
7.4.2 Europe Orexin Receptor Type 2 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Orexin Receptor Type 2 Market Size (2016-2027)
8.2 Asia-Pacific Orexin Receptor Type 2 Market Size by Type
8.2.1 Asia-Pacific Orexin Receptor Type 2 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Orexin Receptor Type 2 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Orexin Receptor Type 2 Market Size by Type (2016-2027)
8.3 Asia-Pacific Orexin Receptor Type 2 Market Size by Application
8.3.1 Asia-Pacific Orexin Receptor Type 2 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Orexin Receptor Type 2 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Orexin Receptor Type 2 Market Size by Application (2016-2027)
8.4 Asia-Pacific Orexin Receptor Type 2 Market Size by Region
8.4.1 Asia-Pacific Orexin Receptor Type 2 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Orexin Receptor Type 2 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Orexin Receptor Type 2 Market Size (2016-2027)
9.2 Latin America Orexin Receptor Type 2 Market Size by Type
9.2.1 Latin America Orexin Receptor Type 2 Market Size by Type (2016-2021)
9.2.2 Latin America Orexin Receptor Type 2 Market Size by Type (2022-2027)
9.2.3 Latin America Orexin Receptor Type 2 Market Size by Type (2016-2027)
9.3 Latin America Orexin Receptor Type 2 Market Size by Application
9.3.1 Latin America Orexin Receptor Type 2 Market Size by Application (2016-2021)
9.3.2 Latin America Orexin Receptor Type 2 Market Size by Application (2022-2027)
9.3.3 Latin America Orexin Receptor Type 2 Market Size by Application (2016-2027)
9.4 Latin America Orexin Receptor Type 2 Market Size by Country
9.4.1 Latin America Orexin Receptor Type 2 Market Size by Country (2016-2021)
9.4.2 Latin America Orexin Receptor Type 2 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Orexin Receptor Type 2 Market Size (2016-2027)
10.2 Middle East & Africa Orexin Receptor Type 2 Market Size by Type
10.2.1 Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2016-2027)
10.3 Middle East & Africa Orexin Receptor Type 2 Market Size by Application
10.3.1 Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2016-2027)
10.4 Middle East & Africa Orexin Receptor Type 2 Market Size by Country
10.4.1 Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Actelion Pharmaceuticals Ltd
11.1.1 Actelion Pharmaceuticals Ltd Company Details
11.1.2 Actelion Pharmaceuticals Ltd Business Overview
11.1.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Introduction
11.1.4 Actelion Pharmaceuticals Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.1.5 Actelion Pharmaceuticals Ltd Recent Development
11.2 Eisai Co Ltd
11.2.1 Eisai Co Ltd Company Details
11.2.2 Eisai Co Ltd Business Overview
11.2.3 Eisai Co Ltd Orexin Receptor Type 2 Introduction
11.2.4 Eisai Co Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.2.5 Eisai Co Ltd Recent Development
11.3 Evotec AG
11.3.1 Evotec AG Company Details
11.3.2 Evotec AG Business Overview
11.3.3 Evotec AG Orexin Receptor Type 2 Introduction
11.3.4 Evotec AG Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.3.5 Evotec AG Recent Development
11.4 Heptares Therapeutics Ltd
11.4.1 Heptares Therapeutics Ltd Company Details
11.4.2 Heptares Therapeutics Ltd Business Overview
11.4.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Introduction
11.4.4 Heptares Therapeutics Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.4.5 Heptares Therapeutics Ltd Recent Development
11.5 Idorsia Ltd
11.5.1 Idorsia Ltd Company Details
11.5.2 Idorsia Ltd Business Overview
11.5.3 Idorsia Ltd Orexin Receptor Type 2 Introduction
11.5.4 Idorsia Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.5.5 Idorsia Ltd Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Orexin Receptor Type 2 Introduction
11.6.4 Johnson & Johnson Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Company Details
11.7.2 Merck & Co Inc Business Overview
11.7.3 Merck & Co Inc Orexin Receptor Type 2 Introduction
11.7.4 Merck & Co Inc Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.7.5 Merck & Co Inc Recent Development
11.8 OptiNose US Inc
11.8.1 OptiNose US Inc Company Details
11.8.2 OptiNose US Inc Business Overview
11.8.3 OptiNose US Inc Orexin Receptor Type 2 Introduction
11.8.4 OptiNose US Inc Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.8.5 OptiNose US Inc Recent Development
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Company Details
11.9.2 Yangtze River Pharmaceutical Group Business Overview
11.9.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Introduction
11.9.4 Yangtze River Pharmaceutical Group Revenue in Orexin Receptor Type 2 Business (2016-2021)
11.9.5 Yangtze River Pharmaceutical Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Orexin Receptor Type 2 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HTL-6641
Table 3. Key Players of MK-8133
Table 4. Key Players of Lemborexant
Table 5. Key Players of OPN-021
Table 6. Key Players of YNT-185
Table 7. Key Players of Others
Table 8. Global Orexin Receptor Type 2 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Orexin Receptor Type 2 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Orexin Receptor Type 2 Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Orexin Receptor Type 2 Market Share by Regions (2016-2021)
Table 12. Global Orexin Receptor Type 2 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Orexin Receptor Type 2 Market Share by Regions (2022-2027)
Table 14. Orexin Receptor Type 2 Market Trends
Table 15. Orexin Receptor Type 2 Market Drivers
Table 16. Orexin Receptor Type 2 Market Challenges
Table 17. Orexin Receptor Type 2 Market Restraints
Table 18. Global Orexin Receptor Type 2 Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Orexin Receptor Type 2 Market Share by Players (2016-2021)
Table 20. Global Top Orexin Receptor Type 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orexin Receptor Type 2 as of 2020)
Table 21. Ranking of Global Top Orexin Receptor Type 2 Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Orexin Receptor Type 2 Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Orexin Receptor Type 2 Product Solution and Service
Table 25. Date of Enter into Orexin Receptor Type 2 Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Orexin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Orexin Receptor Type 2 Revenue Market Share by Type (2016-2021)
Table 29. Global Orexin Receptor Type 2 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Orexin Receptor Type 2 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Orexin Receptor Type 2 Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Orexin Receptor Type 2 Revenue Market Share by Application (2016-2021)
Table 33. Global Orexin Receptor Type 2 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Orexin Receptor Type 2 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Orexin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Orexin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Orexin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Orexin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Orexin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Orexin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Orexin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Orexin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Orexin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Orexin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Orexin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Orexin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Orexin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Orexin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Orexin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Orexin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Orexin Receptor Type 2 Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Orexin Receptor Type 2 Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Orexin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Orexin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Orexin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Orexin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Orexin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Orexin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Orexin Receptor Type 2 Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Orexin Receptor Type 2 Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2022-2027) & (US$ Million)
Table 65. Actelion Pharmaceuticals Ltd Company Details
Table 66. Actelion Pharmaceuticals Ltd Business Overview
Table 67. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product
Table 68. Actelion Pharmaceuticals Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 69. Actelion Pharmaceuticals Ltd Recent Development
Table 70. Eisai Co Ltd Company Details
Table 71. Eisai Co Ltd Business Overview
Table 72. Eisai Co Ltd Orexin Receptor Type 2 Product
Table 73. Eisai Co Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 74. Eisai Co Ltd Recent Development
Table 75. Evotec AG Company Details
Table 76. Evotec AG Business Overview
Table 77. Evotec AG Orexin Receptor Type 2 Product
Table 78. Evotec AG Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 79. Evotec AG Recent Development
Table 80. Heptares Therapeutics Ltd Company Details
Table 81. Heptares Therapeutics Ltd Business Overview
Table 82. Heptares Therapeutics Ltd Orexin Receptor Type 2 Product
Table 83. Heptares Therapeutics Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 84. Heptares Therapeutics Ltd Recent Development
Table 85. Idorsia Ltd Company Details
Table 86. Idorsia Ltd Business Overview
Table 87. Idorsia Ltd Orexin Receptor Type 2 Product
Table 88. Idorsia Ltd Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 89. Idorsia Ltd Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Orexin Receptor Type 2 Product
Table 93. Johnson & Johnson Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 94. Johnson & Johnson Recent Development
Table 95. Merck & Co Inc Company Details
Table 96. Merck & Co Inc Business Overview
Table 97. Merck & Co Inc Orexin Receptor Type 2 Product
Table 98. Merck & Co Inc Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 99. Merck & Co Inc Recent Development
Table 100. OptiNose US Inc Company Details
Table 101. OptiNose US Inc Business Overview
Table 102. OptiNose US Inc Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 103. OptiNose US Inc Recent Development
Table 104. Yangtze River Pharmaceutical Group Company Details
Table 105. Yangtze River Pharmaceutical Group Business Overview
Table 106. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product
Table 107. Yangtze River Pharmaceutical Group Revenue in Orexin Receptor Type 2 Business (2016-2021) & (US$ Million)
Table 108. Yangtze River Pharmaceutical Group Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orexin Receptor Type 2 Market Share by Type: 2020 VS 2027
Figure 2. HTL-6641 Features
Figure 3. MK-8133 Features
Figure 4. Lemborexant Features
Figure 5. OPN-021 Features
Figure 6. YNT-185 Features
Figure 7. Others Features
Figure 8. Global Orexin Receptor Type 2 Market Share by Application: 2020 VS 2027
Figure 9. Insomnia Case Studies
Figure 10. Narcolepsy Case Studies
Figure 11. Sleep Disorders Case Studies
Figure 12. Major Depressive Disorder Case Studies
Figure 13. Orexin Receptor Type 2 Report Years Considered
Figure 14. Global Orexin Receptor Type 2 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Orexin Receptor Type 2 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Orexin Receptor Type 2 Market Share by Regions: 2020 VS 2027
Figure 17. Global Orexin Receptor Type 2 Market Share by Regions (2022-2027)
Figure 18. Global Orexin Receptor Type 2 Market Share by Players in 2020
Figure 19. Global Top Orexin Receptor Type 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orexin Receptor Type 2 as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Orexin Receptor Type 2 Revenue in 2020
Figure 21. Global Orexin Receptor Type 2 Revenue Market Share by Type (2016-2021)
Figure 22. Global Orexin Receptor Type 2 Revenue Market Share by Type (2022-2027)
Figure 23. North America Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Orexin Receptor Type 2 Market Share by Type (2016-2027)
Figure 25. North America Orexin Receptor Type 2 Market Share by Application (2016-2027)
Figure 26. North America Orexin Receptor Type 2 Market Share by Country (2016-2027)
Figure 27. United States Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Orexin Receptor Type 2 Market Share by Type (2016-2027)
Figure 31. Europe Orexin Receptor Type 2 Market Share by Application (2016-2027)
Figure 32. Europe Orexin Receptor Type 2 Market Share by Country (2016-2027)
Figure 33. Germany Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Orexin Receptor Type 2 Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Orexin Receptor Type 2 Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Orexin Receptor Type 2 Market Share by Region (2016-2027)
Figure 43. China Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Orexin Receptor Type 2 Market Share by Type (2016-2027)
Figure 51. Latin America Orexin Receptor Type 2 Market Share by Application (2016-2027)
Figure 52. Latin America Orexin Receptor Type 2 Market Share by Country (2016-2027)
Figure 53. Mexico Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Orexin Receptor Type 2 Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Orexin Receptor Type 2 Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Orexin Receptor Type 2 Market Share by Country (2016-2027)
Figure 59. Turkey Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Orexin Receptor Type 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Actelion Pharmaceuticals Ltd Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 63. Eisai Co Ltd Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 64. Evotec AG Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 65. Heptares Therapeutics Ltd Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 66. Idorsia Ltd Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 68. Merck & Co Inc Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 69. OptiNose US Inc Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 70. Yangtze River Pharmaceutical Group Revenue Growth Rate in Orexin Receptor Type 2 Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed